Collaborative Research Development Grant – Microsoft AI for Health
Ovarian Cancer Research Alliance is requesting Letters of Intent for the 2025 Collaborative Research Development Grant in partnership with Microsoft AI for Health (CRDG-AI). The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects using AI or machine learning that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.

For this opportunity, OCRA is partnering with Microsoft AI for Health, a philanthropic program at Microsoft, which offers access to advanced Microsoft Azure cloud computing and collaboration with data science experts for nonprofits, academia, and researchers working on challenges in the area of health, including ovarian cancer. Investigators funded through this grant opportunity have access to support from Microsoft in the form of Azure computing credits, and in-kind data science support. This in-kind support from Microsoft will be in addition to the financial support from OCRA.

Support of up to $300,000 annually for three years ($900,000 total) will be awarded to the institution(s) in which the recipients will conduct the research.

Collaborative Research Development Grant
Ovarian Cancer Research Alliance is requesting Letters of Intent for the 2025 Collaborative Research Development Grant (CRDG). The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.

Support of up to $300,000 annually for three years ($900,000 total) will be granted to the institution(s) in which the recipients will conduct the research.

Early Career Investigator Grant
Ovarian Cancer Research Alliance is requesting Letters of Intent for the 2025 Early Career Investigator Grant (formerly called the Liz Tilberis Early Career Award). The Early Career Investigator Grant (ECIG) is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research. The intent of these grants is to support a substantial time commitment to research and academic endeavors in ovarian cancer.

Each Early Career Investigator grantee will receive a three-year grant of up to $150,000 per year ($450,000 total).

Health Equity Research Grant
The objective of this grantmaking program is to support research projects that promote equity, inclusivity, and evidence-based approaches to overcome the barriers faced by marginalized communities with a focus on ovarian cancers and/or related gynecologic cancers. For the purposes of this grant, marginalized communities are defined as groups that have historically struggled with equal access to care due to gender identity, sexual orientation, race, ethnicity, disability status, and language barriers. We encourage researchers that are from groups underrepresented in sciences to apply, but this is not a requirement of the grant.

Research Projects may encompass a wide range of research areas, including but not limited to:

• Identifying and addressing social, cultural, and economic factors that contribute to health disparities in ovarian cancer
• Improving access to quality care, diagnostic tools, and treatment options for underserved communities affected by ovarian cancer
• Exploring the impact of racial, ethnic, socioeconomic, or geographic disparities on disease progression and survival rates
• Investigating the genetic and molecular factors influencing ovarian cancer disparities and potential therapeutic approaches
  

Principal Investigators at all stages of their careers are eligible to apply. Support of up to $100,000 annually for two years ($200,000 total) will be awarded to the institution in which the recipient will conduct the research.